MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Positive Psychology to Improve Cardiac Health Behaviors

Not Applicable

Completed

Conditions: Emotions
Acute Coronary Syndrome
Patient Compliance

Interventions: Other: Qualitative Interview and Adherence

First Posted Date: 2013-03-08

Last Posted Date: 2014-09-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01807442

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Regional Lung Inflammation and Expansion in Mechanically Ventilated Patients - a PET/CT Study

Conditions: Respiratory Failure

First Posted Date: 2013-03-07

Last Posted Date: 2017-03-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 10

Registration Number: NCT01806532

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study Assessing the Impact of Dermatology Consultation in Patients Presenting With Possible Cellulitis

Not Applicable

Completed

Conditions: Cellulitis

Interventions: Other: Dermatology Consultation

First Posted Date: 2013-02-20

Last Posted Date: 2013-02-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT01795092

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Non-invasive Brain Modulation for Weight Maintenance

Phase 1

Terminated

Conditions: Obesity

Interventions: Device: Sham modulation
Device: Brain modulation

First Posted Date: 2013-02-18

Last Posted Date: 2016-10-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 13

Registration Number: NCT01793766

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effect of Propofol on Internal Anal Sphincter Pressure During ARM

Completed

Conditions: Chronic Constipation

Interventions: Drug: Propofol

First Posted Date: 2013-02-18

Last Posted Date: 2016-09-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT01793753

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Neurobiological Bases of Placebo Response in Major Depressive Disorder

Phase 4

Terminated

Conditions: Major Depressive Disorder

Interventions: Drug: Placebo
Drug: Escitalopram 10mg

First Posted Date: 2013-02-08

Last Posted Date: 2017-05-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT01787240

Locations: 🇺🇸
Massachusetts General Hospital Depression Clinical and Research Program, Boston, Massachusetts, United States

Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Gilenya
Other: Placebo

First Posted Date: 2013-02-07

Last Posted Date: 2016-07-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01786174

Locations: 🇺🇸
Georgia Regents University, Augusta, Georgia, United States
🇺🇸
Methodist Neurological Institute, Houston, Texas, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 1 locations

Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients

Phase 4

Terminated

Conditions: MRSA - Methicillin Resistant Staphylococcus Aureus Infection

Interventions: Drug: Vancomycin continuous infusion
Drug: Vancomycin intermittent dosing interval

First Posted Date: 2013-02-07

Last Posted Date: 2017-06-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 44

Registration Number: NCT01786161

Locations: 🇺🇸
MGH, Boston, Massachusetts, United States

The Impact of a "Serious Game" on Improving Patient's Medication Knowledge

Not Applicable

Completed

Conditions: Health Knowledge, Attitudes, Practice

Interventions: Behavioral: MasterMed
Behavioral: Usual Care

First Posted Date: 2013-02-07

Last Posted Date: 2017-03-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 850

Registration Number: NCT01786044

Locations: 🇺🇸
Massachusetts General Hospital, Internal Medicine Associates, Boston, Massachusetts, United States

Adjunctive Isradipine for the Treatment of Bipolar Depression

Phase 2

Terminated

Conditions: Bipolar Disorder

Interventions: Drug: Isradipine
Drug: Placebo

First Posted Date: 2013-02-06

Last Posted Date: 2017-04-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2

Registration Number: NCT01784666

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy